In addition, the IL-22-related signaling pathways PGE2/IL22/IL17 and IL-17/IL-22 are receiving increasing attention in eczema, psoriasis, and chronic obstructive pulmonary disease (117, 119). This evidence concerns the gene IL17A and psoriasis.